Intraoperative hyperthermic intraperitoneal chemoperfusion in combined treatment of local-advanced and disseminated gastric cancer
Yarema R.R. 1, Fetsych Т.G.1, Ohorchak М.А.2, Zubarev G.P. 2, Oliynyk Y.Y.1, Matusyak M.B. 2, Zubarev M.G. 1, Gyrya P.I. 2, Kovalchuk Y.Y.2, Safiyan V.I. 2
- 1Danylo Halytsky Lviv National Medical University
- 2The Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical Radiology
Summary. Assesment of results use a novel strategy of combined treatment with hyperthermic intraperitoneal chemoperfusion (HIPEC) in patients with intraperitoneal disseminated gastric cancer was purpose of the study. The frequency of postoperative complications with the use of HIPEC was 26,5%, postoperative mortality — 4,1%. The use of HIPEC in adjuvant regime in patients with high risk of metachronous carcinomatosis permitted to obviously decrease the level of intraperitoneal relapse from 73,7 to 11,1% (р
Leave a comment